A FODMAP diet update: Craze or credible?

Practical Gastroenterology

Volumn 36, Issue 12, 2012, Pages 37-46

  Reggie Thomas, J ^a   Nanda, Rakesh ^b   Shu, Lin H ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISACCHARIDE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; SODIUM GLUCOSE COTRANSPORTER 1;

CARBOHYDRATE DIET; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; HUMAN; HYDROGEN BREATH TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84873625296     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Drossman, DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45(suppl 2):1-5.
2. Nanda, R, James, R, Smith H et al. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
3. Bentley, SJ, Pearson, DJ, Rix KJ. Food hypersensitivity in irritable bowel syndrome. Lancet 1983;2:295-7.
4. Gibson, PR, Newnham, E, Barrett JS, et al. Review article: fructose malabsorption and the bigger picture. Aliment. Pharmacol There. 2007;25:349-63.
5. Nussey, S, Whitehead, S. Endocrinology: An Integrated Approach. Oxford: BIOS Scientific Publishers; 2001. Box 2.3. Absorption of monosaccharides in the small intestine.
6. Ferraris, RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J. 2001;360:265-6.
7. Pessin, JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol. 1992;54:911-30.
8. Thorens, B, Cheng, ZQ, Brown D. et al. Liver glucose transporter: a basolateral protein in hepatocytes and intestine and kidney cells. Am J Physiol. 1990;259:C279-85.
9. Cheeseman CI. Intestinal hexose absorption: transcellular or paracellular fluxes. J Physiol. 2002;544:336.
10. Castello, A, Guma, A, Sevilla L, et al. Regulation of GLUT5 gene expression in rate intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes. Biochem J. 1995;309:271-7.
11. Croagh, C, Shepherd SJ, et al. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflammatory Bowel Diseases 2007;13(12):1522-8.
12. Gibson, PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology & Hepatology 2010;25(2):252-8.
13. Choi, YK, Johlin, FC, Summers RW et al. Fructose intolerance: an under recognized problem. Am J Gastroenterol. 2003;98:1348-1353.
14. Symons, P, Jones, MP, Kellow JE. Symptoms provocation in irritable bowel syndrome. Effects of differing doses of fructose sorbitol. Scan J Gastroenterol. 1992;27:940-944.
15. Shepherd, SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J. Am. Diet. Assoc. 2006;106:1631-9.
16. Shepherd, SJ, Parker, FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo controlled evidence. Clin. Gastroenterol. Hepatol 2008;6:765-71.
17. Barrett, JS, Gearry, RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment. Pharmacol. There. 2010;31:874-82.
18. Ong, DK, Mitchell, SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J. Gastroenterol. Hepatol. 2010;25:1366-72.
19. Staudacher, HM, Whelan, K,Irving PM et al.Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. Journal of Human Nutrition & Dietetics 2011;24(5):487-95.
20. Barrett, JS, Irving, PM, Shepherd SJ et al. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment. Pharmacol There. 2009;30:165-74.
21. Gearry, RB, Irving, PM, Barrett JS et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPS) improves abdominal symptoms in patients with inflammatory bowel disease- a pilot study. J. Crohns Colitis 2009;3:8-14.
22. Gibson, PR, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol & Therap. 2005;21(12):1399-409.
23. Halmos, EP, Liels, KL, Rosella O. Enteral and oral nutritional supplement formulas deliver laxative doses of FODMAPs which cannot be predicted by ingredients lists. Journal of Gastroenterology and Hepatology 2011;26(suppl 4):73.
24. Halmos, EP, Muir, JG, Barrett JS et al. Diarrhoea during enteral nutrition is predicted by the poorly absorbed short-chain carbohydrate (FODMAP) content of the formula. Aliment Pharmacol Ther. 2010;32(7):925-933.
25. Gibson, PR. Food intolerance in functional bowel disorders. Journal of Gastroenterology & Hepatology 2011;26(suppl 3):128-31.